{"id":"https://openalex.org/W2011373763","doi":"https://doi.org/10.1373/clinchem.2010.148833","title":"Therapeutic Approaches to Target Inflammation in Type 2 Diabetes","display_name":"Therapeutic Approaches to Target Inflammation in Type 2 Diabetes","alternate_titles":[],"publication_year":2011,"publication_date":"2011-02-01","ids":{"openalex":"https://openalex.org/W2011373763","doi":"https://doi.org/10.1373/clinchem.2010.148833","mag":"2011373763","pmid":"https://pubmed.ncbi.nlm.nih.gov/21098138","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3227024"},"language":"en","primary_location":{"id":"doi:10.1373/clinchem.2010.148833","doi":"https://doi.org/10.1373/clinchem.2010.148833","is_oa":true,"landing_page_url":"https://doi.org/10.1373/clinchem.2010.148833","pdf_url":"https://academic.oup.com/clinchem/article-pdf/57/2/162/32654743/clinchem0162.pdf","source":{"id":"https://openalex.org/S139212996","display_name":"Clinical Chemistry","issn_l":"0009-9147","issn":["0009-9147","1530-8561"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320272","host_organization_name":"American Association for Clinical Chemistry","host_organization_lineage":["https://openalex.org/P4310320272"],"host_organization_lineage_names":["American Association for Clinical Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011373763"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/clinchem/article-pdf/57/2/162/32654743/clinchem0162.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032424150","display_name":"Allison B. Goldfine","orcid":"https://orcid.org/0000-0002-0345-1048","observed_orcids":["https://orcid.org/0000-0002-0345-1048"]},"institutions":[{"id":"https://openalex.org/I1293231726","display_name":"Joslin Diabetes Center","ror":"https://ror.org/0280a3n32","country_code":"US","type":"facility","lineage":["https://openalex.org/I1293231726"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Allison B Goldfine","raw_affiliation_strings":["Department of Medicine, Harvard Medical School, Boston, MA","Joslin Diabetes Center and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Joslin Diabetes Center and","institution_ids":["https://openalex.org/I1293231726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034671525","display_name":"Vivian Andrew Fonseca","orcid":"https://orcid.org/0000-0002-3381-7151","observed_orcids":["https://orcid.org/0000-0002-3381-7151"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vivian Fonseca","raw_affiliation_strings":["Department of Medicine, Section of Endocrinology, Tulane University, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Section of Endocrinology, Tulane University, New Orleans, LA","institution_ids":["https://openalex.org/I114832834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004903799","display_name":"Steven E. Shoelson","orcid":"https://orcid.org/0000-0003-2609-7472","observed_orcids":["https://orcid.org/0000-0003-2609-7472"]},"institutions":[{"id":"https://openalex.org/I1293231726","display_name":"Joslin Diabetes Center","ror":"https://ror.org/0280a3n32","country_code":"US","type":"facility","lineage":["https://openalex.org/I1293231726"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven E Shoelson","raw_affiliation_strings":["Department of Medicine, Harvard Medical School, Boston, MA","Joslin Diabetes Center and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Joslin Diabetes Center and","institution_ids":["https://openalex.org/I1293231726"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5032424150"],"corresponding_institution_ids":["https://openalex.org/I1293231726","https://openalex.org/I136199984"],"apc_list":{"value":4636,"currency":"USD","value_usd":4636},"apc_paid":null,"fwci":1.8224,"has_fulltext":true,"cited_by_count":126,"citation_normalized_percentile":{"value":0.87484355,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"57","issue":"2","first_page":"162","last_page":"167"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8730000257492065},{"id":"https://openalex.org/keywords/chronic-inflammation","display_name":"chronic inflammation","score":0.9369999766349792},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.8370000123977661},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8450000286102295},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.7990000247955322},{"id":"https://openalex.org/keywords/salicylates","display_name":"salicylates","score":0.8790000081062317},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/hypoglycemic-effect","display_name":"hypoglycemic effect","score":0.9380000233650208},{"id":"https://openalex.org/keywords/diet-induced-obesity","display_name":"diet-induced obesity","score":0.9470000267028809},{"id":"https://openalex.org/keywords/adiposity","display_name":"adiposity","score":0.7630000114440918}],"concepts":[{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.8116725087165833},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.8030350804328918},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.798222541809082},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7744719982147217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7226575613021851},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6979427337646484},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.6152903437614441},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.6023603677749634},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.4930715262889862},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4470941424369812},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4352138638496399},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24230560660362244},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.19375985860824585},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13088253140449524}],"mesh":[{"descriptor_ui":"D000273","descriptor_name":"Adipose Tissue","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012459","descriptor_name":"Salicylates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1373/clinchem.2010.148833","doi":"https://doi.org/10.1373/clinchem.2010.148833","is_oa":true,"landing_page_url":"https://doi.org/10.1373/clinchem.2010.148833","pdf_url":"https://academic.oup.com/clinchem/article-pdf/57/2/162/32654743/clinchem0162.pdf","source":{"id":"https://openalex.org/S139212996","display_name":"Clinical Chemistry","issn_l":"0009-9147","issn":["0009-9147","1530-8561"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320272","host_organization_name":"American Association for Clinical Chemistry","host_organization_lineage":["https://openalex.org/P4310320272"],"host_organization_lineage_names":["American Association for Clinical Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Chemistry","raw_type":"journal-article"},{"id":"pmid:21098138","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21098138","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3227024","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3227024/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Chem","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.963.6080","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.963.6080","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://clinchem.aaccjnls.org/content/clinchem/57/2/162.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.963.7133","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.963.7133","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://clinchem.aaccjnls.org/content/clinchem/early/2010/11/22/clinchem.2010.148833.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1373/clinchem.2010.148833","doi":"https://doi.org/10.1373/clinchem.2010.148833","is_oa":true,"landing_page_url":"https://doi.org/10.1373/clinchem.2010.148833","pdf_url":"https://academic.oup.com/clinchem/article-pdf/57/2/162/32654743/clinchem0162.pdf","source":{"id":"https://openalex.org/S139212996","display_name":"Clinical Chemistry","issn_l":"0009-9147","issn":["0009-9147","1530-8561"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320272","host_organization_name":"American Association for Clinical Chemistry","host_organization_lineage":["https://openalex.org/P4310320272"],"host_organization_lineage_names":["American Association for Clinical Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1016455083","display_name":"Mechanism-Based Biomarkers for Glucose-Lowering in TINSAL-T2D","funder_award_id":"RC4DK090792","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G1635256147","display_name":"Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate","funder_award_id":"U01DK074556","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G2714337920","display_name":"EFFECTS OF IKKB and NFkB IN INSULIN RESISTANCE","funder_award_id":"R01DK045943","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G2830412866","display_name":"IKK MEDIATED INSULIN RESISTANCE AND IN VIVO REVERSAL","funder_award_id":"R01DK051729","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G2872377240","display_name":"General Clinical Research Center","funder_award_id":"M01RR001032","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G2987238485","display_name":"Mediators and Modifiers of NF-kappaB in Insulin Resistance","funder_award_id":"R37DK051729","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G3543255528","display_name":"TOLL RECEPTOR ACTIVATION OF NF-kB IN INSULIN RESISTANCE AND T2DM","funder_award_id":"R01DK073547","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G4167249614","display_name":"General Clinical Research Center","funder_award_id":"M01RR002635","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G7148665356","display_name":"Targeting Inflammation to Improve Endothelial Function in Type 2 Diabetes: A Subs","funder_award_id":"R01HL091750","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G8593633075","display_name":"Metabolic Syndrome, Inflammation and Vascular Remodeling","funder_award_id":"P50HL083813","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G9000868266","display_name":"Diabetes Research Center","funder_award_id":"P30DK036836","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2011373763.pdf","grobid_xml":"https://content.openalex.org/works/W2011373763.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W55232514","https://openalex.org/W146577346","https://openalex.org/W174705705","https://openalex.org/W1534360145","https://openalex.org/W1546304862","https://openalex.org/W1579034036","https://openalex.org/W1599412415","https://openalex.org/W1979302001","https://openalex.org/W1982112254","https://openalex.org/W1985534077","https://openalex.org/W1991401793","https://openalex.org/W1992241296","https://openalex.org/W2005463782","https://openalex.org/W2010237936","https://openalex.org/W2013760718","https://openalex.org/W2013895711","https://openalex.org/W2018135697","https://openalex.org/W2024378513","https://openalex.org/W2029128612","https://openalex.org/W2031637294","https://openalex.org/W2047852384","https://openalex.org/W2049501468","https://openalex.org/W2054415546","https://openalex.org/W2075584741","https://openalex.org/W2092126384","https://openalex.org/W2098217678","https://openalex.org/W2102177965","https://openalex.org/W2104918369","https://openalex.org/W2110500106","https://openalex.org/W2113184924","https://openalex.org/W2113477705","https://openalex.org/W2121535401","https://openalex.org/W2125058279","https://openalex.org/W2129316761","https://openalex.org/W2132128152","https://openalex.org/W2137156143","https://openalex.org/W2137983259","https://openalex.org/W2139203772","https://openalex.org/W2140234457","https://openalex.org/W2151672809","https://openalex.org/W2152213031","https://openalex.org/W2152377123","https://openalex.org/W2153188717","https://openalex.org/W2160375807","https://openalex.org/W2316376271","https://openalex.org/W3022401702","https://openalex.org/W4246592598"],"related_works":["https://openalex.org/W2152377123","https://openalex.org/W2249101516","https://openalex.org/W1974373780","https://openalex.org/W2560939303","https://openalex.org/W4377043205","https://openalex.org/W2150367899","https://openalex.org/W2117013534","https://openalex.org/W1144328396","https://openalex.org/W3021704619","https://openalex.org/W2941975309"],"abstract_inverted_index":{"BACKGROUND:":[0],"Chronic":[1],"inflammation":[2,55],"may":[3,18],"participate":[4],"in":[5],"the":[6,52,83,113,120],"pathogenesis":[7],"of":[8,88,94,115,123],"insulin":[9,98],"resistance,":[10,99],"type":[11,100],"2":[12,101],"diabetes,":[13,102],"and":[14,17,40,45,70,85,103],"cardiovascular":[15,41,104],"disease":[16,28,42,58,68,105],"be":[19],"a":[20,80],"common":[21],"denominator":[22],"that":[23,54],"links":[24],"obesity":[25,96],"to":[26,37,51,62,76,118],"these":[27,57,65],"states.":[29],"CONTENT:":[30],"Epidemiologic":[31],"studies":[32,47],"have":[33,48],"linked":[34],"inflammatory":[35],"biomarkers":[36],"incident":[38],"diabetes":[39],"risk.":[43],"Cellular":[44],"animal":[46],"provided":[49],"support":[50],"idea":[53],"mediates":[56],"processes,":[59],"providing":[60],"impetus":[61],"pharmacologically":[63],"target":[64,77],"pathways":[66],"for":[67,112],"treatment":[69],"prevention.":[71],"We":[72],"review":[73],"clinical":[74],"strategies":[75,117],"inflammation,":[78],"with":[79],"focus":[81],"on":[82],"antiinflammatory":[84,116],"antihyperglycemic":[86],"effects":[87],"salicylates.":[89],"SUMMARY:":[90],"The":[91],"evolving":[92],"concept":[93],"diet-induced":[95],"driving":[97],"through":[106],"immunologic":[107],"processes":[108],"provides":[109],"new":[110],"opportunities":[111],"use":[114],"correct":[119],"metabolic":[121],"consequences":[122],"excess":[124],"adiposity.":[125]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011373763","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":21},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
